December 10, 2018
CMR Surgical named sixth in the list of Britain’s Top 100 Fastest-Growing Businesses in the UK in 2018
December 10, 2018
CMR Surgical named sixth in the list of Britain’s Top 100 Fastest-Growing Businesses in the UK in 2018

CMR Surgical, the British company developing a next-generation surgical robot, has been revealed as sixth in a list of Britain’s Top 100 Fastest-Growing Businesses in the UK in 2018. The rapidly-growing company is the highest ranking medical devices business in the list, which has been published by the Syndicate Room.

CMR Surgical

Sarah Ghabina

Communications Lead

T: +44 01223 755801

Martin Frost, Chief Executive Officer of CMR Surgical, commented: “This is great recognition of a transformational year for CMR Surgical. The support from our investors, both new and existing, and the hard-work of our world-class team, has enabled the rapid growth of our company in 2018. This all gets us closer to our goal of delivering the benefits of minimal access surgery to all who need it.  We are now firmly focused on 2019 and launching Versius to the NHS and the wider world.”

The listing comes just months after CMR Surgical announced a record-breaking Series B funding round of $100million; the largest ever Series B raise by a medical devices company in Europe. The company, which designed the surgical robotic system Versius®, has also more than doubled in size over the past year, now employing over 250 people. CMR is now moving into a 55,000 sq. ft global headquarters on the outskirts of Cambridge.

Follow this link to download the publication:


About CMR Surgical

CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius®, for minimal access surgery.

The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.

Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1

CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base. The Company achieved the registration of its Quality Management System to ISO 13485:2016 by Underwriters Laboratories LLC®(‘UL’), and the status as a UL Registered Firm, in September 2015.

For further information, please visit

About Versius, the CMR Surgical robotic system

Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily into the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort.  Intended to be used across a range of surgical specialties, the versatility and portability of Versius, enabled by a unique and patented four-axis wrist joint, expands the potential for higher utilisation. The versatility of the system and compelling commercial model allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.

1 Industry Forecast, Accuray Research